Castuner

Hormone Insight

FWA

Discuss Diabetes and Endocrinology studies in a simplified manner. Expand your knowledge in Diabetes and Endocrinology.

Podcast website

Listen in your app

Episodes

44 episodes

  1. Romosozumab 3 vs 12: 3 months of romosozumab | Hormone Insight Podcast 3:51
  2. CHIRACIC: Surgery for mild cortisol excess? | Hormone Insight Podcast 4:05
  3. TRAVERSE: Is testosterone heart-safe? | Hormone Insight Podcast 4:00
  4. Statin side effects: Which ones are real? | Hormone Insight Podcast 4:08
  5. CLEAR Outcomes: Statin-intolerant patients | Hormone Insight Podcast 4:09
  6. LT4 withdrawal: Can we stop levothyroxine? | Hormone Insight Podcast 3:50
  7. ORBIT: IL-17 for thyroid eye disease? | Hormone Insight Podcast 3:52
  8. GRASS: Selenium in Graves' | Hormone Insight Podcast 3:37
  9. ESTIMABL2: No radioiodine at 5 years | Hormone Insight Podcast 4:10
  10. IoN: Skip radioiodine? | Hormone Insight Podcast 4:05
  11. Rosiglitazone: A heart attack signal? | Hormone Insight Podcast 3:54
  12. Closed-loop under 7: Automated insulin delivery | Hormone Insight Podcast 3:51
  13. GRADE: Fewer admissions? Not so fast | Hormone Insight Podcast 3:54
  14. SURPASS-4: Tirzepatide and the kidney | Hormone Insight Podcast 4:39
  15. SOUL: Oral semaglutide and the heart | Hormone Insight Podcast 4:09
  16. SELECT: Weight drug, heart benefit | Hormone Insight Podcast 4:02
  17. STEP TEENS: Semaglutide for teens | Hormone Insight Podcast 4:03
  18. ATTAIN-MAINTAIN: Keeping the weight off | Hormone Insight Podcast 4:21
  19. STEP-1: What happens when you stop? | Hormone Insight Podcast 4:06
  20. SURMOUNT-1: 20% weight loss | Hormone Insight Podcast 4:08
  21. POLY-HF: One pill for heart failure? | Hormone Insight Podcast 4:21
  22. SUMMIT: Tirzepatide in HFpEF | Hormone Insight Podcast 4:22
  23. EMPA-KIDNEY: SGLT2 for all CKD | Hormone Insight Podcast 4:32
  24. FLOW: Semaglutide and the kidney | Hormone Insight Podcast 4:56
  25. FIND-CKD: Finerenone beyond diabetes | Hormone Insight Podcast 4:58
  26. Prednisolone Once Daily vs Thrice-Daily Hydrocortisone in Adrenal Insufficiency: RCT Evidence 4:42
  27. VESALIUS-CV: Evolocumab Before a First Heart Attack or Stroke 3:53
  28. CATALYST: Mifepristone, HbA1c and Treatment Burden -- Clinical Evidence for Doctors 10:41
  29. SOUL: Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes 8:03
  30. STEP 1 Trial Explained: Semaglutide 2.4 mg for Obesity in 2 Minutes 1:33
  31. Jun 27, 2026: This Week in Diabetes & Endocrinology -- The triple agonist arrives, and the bar moves 11:58
  32. An Oral GLP-1 That Works: ATTAIN-2 and the 2026 ADA Standards | This Week in Diabetes & Endocrinology 9:32
  33. The Week in Endocrinology Oral Ozempic & Emerging Therapies 5:01
  34. Week in Diabetes & Endocrinology (May 4, 2026): AID in Pregnancy, Tirzepatide ICERs, AACE Signals, Dapagliflozin & Anemia, Hypoglycemia Models, Oat Diet Trial 15:56
  35. HORMONE INSIGHT -- THE WEEK IN DIABETES & ENDOCRINOLOGY -- Episode 004 | April 24, 2026 13:32
  36. The Week in Diabetes and Endocrinology April 17, 2026 17:41
  37. Episode 002: LDL Under 55 Wins Big, Medicare Covers GLP-1, and Second Weekly Insulin Emerges -- The Week in Diabetes & Endocrinology (April 10, 2026) 16:45
  38. The Week in Diabetes and Endocrinology -- April 3, 2026 23:36
  39. Early Onset Type 2 Diabetes and Tirzepatide (SURPASS Post Hoc Analysis) 1:14
  40. Exploring Semaglutide: Therapy for Obesity and Heart Failure 0:51
  41. Semaglutide vs Canagliflozin for Type 2 Diabetes 1:04
  42. Study Shows Tirzepatide Improves Heart Failure Outcomes and Quality of Life in Obese Patients 3:38
  43. Intensive Blood-Pressure Control in Patients with Type 2 Diabetes 3:36
  44. Phase 2 trial on Semaglutide 3:39